Key result
Assay-agnostic 3C algorithm shows comparable MI sensitivity and specificity to ESC 0/1h and 0/2h algorithms.
Why the study?
Diagnostic algorithms for suspected MI are limited by reliance on assay-specific hs-cTn cut-offs, prompting evaluation of the assay-independent common change criteria (3C) algorithm against established ESC algorithms.
Does the 3C algorithm for hs-cTn provide comparable diagnostic performance to established ESC algorithms for rule-in and rule-out of MI in patients presenting to the emergency department?
Cohort (n=5,011)
Yes
Does the 3C algorithm for hs-cTn provide comparable diagnostic performance to established ESC algorithms for rule-in and rule-out of MI in patients presenting to the emergency department?
Answers are grounded in this paper and cite their sources.
The assay-agnostic 3C algorithm performs similarly to established ESC 0/1h and 0/2h algorithms for risk stratifying patients with suspected MI, offering a universal approach across different hs-cTn assays.
Background A major limitation of diagnostic algorithms for suspected myocardial infarction (MI) is their reliance on assay-specific high-sensitivity cardiac troponin (hs-cTn) cut-off concentrations and change criteria. Recently, the common change criteria (3C) have been proposed as an approach to risk stratification which utilizes universal, assay-independent criteria for hs-cTn assays Purpose We sought to evaluate a 3C algorithm for hs-cTn and compare its performance to established algorithms for the rule-out and rule-in of MI. Methods We used data from two prospective cohort studies (with 3 different hs-cTn assays) of patients presenting to the emergency department with suspected MI who had serial hs-cTn results available: the Biomarkers in Acute Cardiac Care (BACC) cohort from Germany and the Christchurch cohort from New Zealand. The 3C algorithm was applied and compared to established ESC algorithms (Figure 1). Diagnostic performance measures (sensitivity, specificity, predictive values, likelihood ratios) for MI were obtained for both 3C (change criteria >|3| for under 10 ng/L, >|30|% between 10-100 ng/L and >|15|% for above 100 ng/L) and the ESC algorithms for rule-in and rule-out. Confusion matrices, net reclassification improvement (NRI), and effectiveness (percentage rule-in and rule-out) analyses were also performed. Results In 5011 patients, the MI prevalence was 16.12% (n=811). Comparable diagnostic accuracy in terms of sensitivity, specificity, and predictive values were observed between the 3C and ESC algorithms. Direct comparison of the algorithms via NRI showed no decisive advantage for either algorithm (Figure 2). Confusion matrices for all three assays for both 0/1h and 0/2h sampling identified that the 3C ruled-in more patients with a MI who were ruled-out with the ESC. Conclusions The 3C algorithm performs similarly to the ESC 0/1h and 0/2h algorithms for risk stratifying patients for possible MI across three different hs-cTn assays. The 3C algorithm has the advantage of being assay-agnostic and has demonstrated comparable performance in the settings of both the 0/1h and 0/2h sampling.
No takes yet. Share an insight, caveat, or question.
Thiessen et al. (2025) conducted a cohort in Suspected myocardial infarction (n=5,011). 3C algorithm for hs-cTn vs. ESC 0/1h and 0/2h algorithms was evaluated on Diagnostic performance for MI (sensitivity, specificity, predictive values, likelihood ratios). In patients, the assay-agnostic 3C algorithm performed similarly to established ESC 0/1h and 0/2h algorithms for risk stratifying patients for possible MI.
Synapse has enriched 10 related papers. Consider them for comparative context: